glp 1 access Fighting for GLP-1 Access: Advocacy with Amanda Bonello Navigating GLP-1 use in therapy

FUTURE PERSPECTIVES Long-term outcomes While strong evidence supports the kidney-protective effects of both SGLT2 inhibitors and GLP-1 receptor agonists, the long-term durability of these benefits remains uncertain (Table 2)

So why wouldnt you want to take these things and theyre selling an awful lot of them

They promote a shift from pro-inflammatory M1 macrophages to anti-inflammatory M2 macrophages, thereby creating a reparative hepatic environment (25)

Nonadherence was determined based on the date of treatment discontinuation with GLP1 RA or metformin, day 90 (index) if no further prescription than the initial was redeemed

Together, they provide valuable insights into how GLP-1 medications can transform health beyond just weight loss

You dont have to do this alone